Portopulmonary hypertension and serum endothelin-1 levels in patients with liver cirrhosis
Monaldi Archives for Chest Disease · 10.06.2026
DOI: 10.4081/monaldi.2026.3093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Monaldi Archives for Chest Disease, online erschienen am 10.06.2026. Verfasst von Akshyaya Pradhan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A broad body of evidence has accrued, demonstrating the role of endothelin-1 (ET-1) in the pathophysiology of pulmonary arterial hypertension. Furthermore, the role of ET-1 as a causative pathophysiological mechanism of portopulmonary hypertension (POPH) has been consistently implicated; however, there is a lack of satisfactory evidence supporting this assertion. Thus, the present study aims to determine the prevalence of POPH among patients with hepatic cirrhosis, determine the serum ET-1 levels among these patients, and investigate the association between ET-1 and POPH in subjects with hepatic cirrhosis. A prospective, observational study was conducted from September 2017 to August 2018. Detailed history and examination with relevant investigations, including echocardiography, were performed for patients with and without POHP. ET-1 levels were significantly higher among patients with POPH compared to those without POPH. Moreover, the ET-1 cut-off level of 82 pg/mL correctly predicted the 9.3% prevalence of POPH in patients with hepatic cirrhosis with 100% sensitivity and 100% negative predictive value. The ET-1 cut-off level of 82 pg/mL may be used as a biomarker of POPH in patients with hepatic cirrhosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh.
- Department of Internal Medicine, King George's Medical University, Lucknow, Uttar Pradesh.
- Department of Respiratory Medicine, King George's Medical University, Lucknow, Uttar Pradesh.
- Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh.
- Department of Human Science and Promotion of Quality of Life, San Raffaele Open University, Rome.
- Division of Cardiology and CardioLab, Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome.
Zitieren
APA
Pradhan, A., Gupta, A., Bajpai, J., Bhandari, M., Singh, A., Pandey, S., Usman, K., Caminiti, G., Iellamo, F., Kumar, A., Mehrotra, S., & Perrone, M. A. (2026). Portopulmonary hypertension and serum endothelin-1 levels in patients with liver cirrhosis. Monaldi Archives for Chest Disease. https://doi.org/10.4081/monaldi.2026.3093
Vancouver
Pradhan A, Gupta A, Bajpai J, Bhandari M, Singh A, Pandey S, et al. Portopulmonary hypertension and serum endothelin-1 levels in patients with liver cirrhosis. Monaldi Archives for Chest Disease. 2026. doi:10.4081/monaldi.2026.3093
BibTeX
@article{Pradhan2026,
author = {Pradhan, Akshyaya and Gupta, Anany and Bajpai, Jyoti and Bhandari, Monika and Singh, Abhishek and Pandey, Shivani and Usman, Kauser and Caminiti, Giuseppe and Iellamo, Ferdinando and Kumar, Ajay and Mehrotra, Sanjay and Perrone, Marco Alfonso},
title = {Portopulmonary hypertension and serum endothelin-1 levels in patients with liver cirrhosis},
journal = {Monaldi Archives for Chest Disease},
year = {2026},
doi = {10.4081/monaldi.2026.3093}
}
EUVIMED